Open access
Sep 2026
Pharmacogenomics-guided therapy for essential hypertension: a multi-center randomized controlled open-label trial
Background The advent of pharmacogenomics-guided antihypertensive therapy represents a paradigm shift in hypertension management. This study aimed to investigate the prevalence of relevant genetic variants among hypertensive patients in Hunan Province, China, and evaluate the efficacy of genotype-directed vs. clinicall...
Sha Wu, Wen-Wu Liu, Long Chen et al.
· Frontiers in Cardiovascular... · 0 citations